Form 4: Imunon CEO Receives Stock Grant
Insider Transaction (Form 4)
Stacy Lindborg, President and CEO and a Director of Imunon, Inc., received 2,977 shares of common stock on October 9, 2026.
Summary
- Grant/award: acquired 2,977 Common Stock at $1.08 ($3,215) on October 9, 2026; holds 116,174 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Stacy Lindborg — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-09 | Grant/award | Common Stock | 2,977 | $1 | $3.2K | 116,174 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-09 | Grant/award (2,977 shares) |
Keywords
insider transaction, Form 4, IMNN, Imunon, Inc., neutral, Stacy Lindborg
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.